FDA decisions on new oncological drugs

Lancet Oncol. 2022 May;23(5):583-585. doi: 10.1016/S1470-2045(22)00136-X.

Authors

Guanqiao Li, Yang Liu, Ruyi He, Ling Su, Xiaoyuan Chen

PMID: 35489340
DOI: 10.1016/S1470-2045(22)00136-X

No abstract available

MeSH terms

Humans
Medical Oncology*
United States
United States Food and Drug Administration